RAD51AP1 as an Immune-Related Prognostic Biomarker and Therapeutic Response Predictor in Hepatocellular Carcinoma.

Yongguang WeiChenlu LanXiangkun WangXin ZhouXiwen LiaoHuasheng HuangZhongliu WeiTianman LiTao Peng Guangzhi Zhu

Published in: International journal of general medicine (2023)

is a potential diagnostic and prognostic biomarker. It may be related to the immunosuppressive microenvironment and could be an underlying HCC treatment strategy. However, the conclusions still require further validation studies.

Keyphrases

stem cells
risk assessment
oxidative stress